Fleur van der Sijde

4PUBLICATIONS
10CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 18, 2022
Treatment Response and Conditional Survival in Advanced Pancreatic Cancer Patients Treated with FOLFIRINOX: A Multicenter Cohort Study.

Fleur van der Sijde, Jacob L van Dam, Bas Groot Koerkamp

|Sep 28, 2021
Organoids Derived from Neoadjuvant FOLFIRINOX Patients Recapitulate Therapy Resistance in Pancreatic Ductal Adenocarcinoma.

Elham Aida Farshadi, Jiang Chang, Bharath Sampadi

|Aug 23, 2021
Circulating TP53 mutations are associated with early tumor progression and poor survival in pancreatic cancer patients treated with FOLFIRINOX.

Fleur van der Sijde, Zakia Azmani, Marc G Besselink

Pageof 1